Company: BIVIW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001520138-25-000343
Chunk: 48

Company: BIOVIE INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 8
Chunk 48
---
    13

6.Fair Value Measurements

Financial assets

As of September 30, 2025, investments in U.S.
Treasury Bills were valued through use of quoted prices and are classified as Level 1. The following table presents information about
our assets that are measured at fair value on a recurring basis using the above input categories. 

    Measured at fair value on a recurring basis 

    Fair Value Measurements at 

    September 30, 2025 

    Level 1  
    Level 2  
    Level 3  
    Total 

    Cash 
    $3,346,904  
    $-  
    $-  
    $3,346,904 
  
    U.S. Treasury Bills due in 3 months or less at purchase 
     21,631,398  
     -  
     -  
     21,631,398 

    Total 
    $24,978,302  
    $-  
    $-  
    $24,978,302 

    Fair Value Measurements at 

    June 30, 2025 

    Level 1  
    Level 2  
    Level 3  
    Total 

    Cash 
    $3,978,271  
    $-  
    $-  
    $3,978,271 
  
    U.S. Treasury Bills due in 3 months or less at purchase 
     13,566,276  
     -  
     -  
     13,566,276 

    Total 
    $17,544,547  
    $-  
    $-  
    $17,544,547 

7.Equity Transactions

Equity Transactions with Acuitas (former related
party)

On July 15, 2022, the Company entered into a securities
purchase agreement with Acuitas Group Holdings, LLC (“Acuitas”), the Company’s largest stockholder, pursuant to which
Acuitas agreed to purchase from the Company, in a private placement, (i) an aggregate of 36,364 shares of the Company’s Common Stock,
at a price of $165.00 per share (the “PIPE Shares”), and (ii) a warrant to purchase 72,728 shares of Common Stock (“PIPE
Warrant Shares”), at an original exercise